Pliant Therapeutics Investors

22 investors on Angel Roster list Pliant Therapeutics in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States.

Investors are matched on the company name in their portfolio, so companies that share the name Pliant Therapeutics can appear together.

Investors listed
22
With verified email
41%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 22 Pliant Therapeutics investors

The most complete profiles first. Showing 22 of 22.

  • Christoph LengauerVerified

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Verified email available

  • Craig MuirVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Verified email available

  • Geeta VemuriVerified

    Venture Capital, Founder, Private Equity Firm · United States

    Series AHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Entrada Therapeutics, Orchard Therapeutics, Skyhawk Therapeutics, Aptinyx and 12 more

    Verified email available

  • Grace GeVerified

    Venture Capital, Investor · United States

    Series BHealth CareRemote Work TechEnterprise SoftwareHR Tech

    Portfolio: Everlaw, OpenSpace, Photomath, Fleetsmith and 73 more

    Verified email available

  • Greg YapVerified

    Venture Capital, Private Equity Firm, Finance Operator · United States

    Series BAdvertisingHealth CareE-commerceCybersecurity

    Portfolio: Everlaw, OpenSpace, Photomath, Fleetsmith and 73 more

    Verified email available

  • Robert TepperVerified

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Verified email available

  • Shawn CarolanVerified

    Venture Capital, Private Equity Firm, Finance Operator · United States

    Series BAdvertisingHealth CareE-commerceCybersecurity

    Portfolio: PlaySpan, Everlaw, OpenSpace, IMVU and 78 more

    Verified email available

  • JeanVerified

    Venture Capital, Private Equity Firm, Finance Operator · United States

    AdvertisingHealth CareE-commerceCybersecurity

    Portfolio: Everlaw, OpenSpace, Photomath, Fleetsmith and 73 more

    Verified email available

  • Noreen RizviVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Verified email available

  • Rob FaulknerVerified

    Hedge Fund, Venture Capital, Private Equity Firm · United States

    Health CareHospitalsGeneticsWomen Founded

    Portfolio: Lifesprout, Blueprint Medicines, OncoResponse, CorVent Medical and 73 more

    Contact details available

  • Abbie Celniker

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 54 more

    Contact details available

  • Cary Pfeffer

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

  • Croom Beatty

    Venture Capital, Private Equity Firm, Finance Operator · United States

    Series BAdvertisingHealth CareE-commerceCybersecurity

    Portfolio: Everlaw, OpenSpace, Photomath, Fleetsmith and 74 more

    Contact details available

  • George Xu

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

  • Mark Levin

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceEducation

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

  • Neil Exter

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

  • Preston Noon

    Venture Capital, Private Equity Firm, Micro VC · United States

    Series AHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Entrada Therapeutics, Orchard Therapeutics, Skyhawk Therapeutics, Aptinyx and 9 more

    Contact details available

  • Gerard van Hamel Platerink

    Hedge Fund, Venture Capital, Private Equity Firm · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Lifesprout, Blueprint Medicines, OncoResponse, CorVent Medical and 73 more

    Contact details available

  • JORDAN ORMONT

    Venture Capital, Private Equity Firm, Finance Operator · United States

    AdvertisingHealth CareE-commerceCybersecurity

    Portfolio: Everlaw, OpenSpace, Photomath, Fleetsmith and 73 more

    Contact details available

  • Kelly Moynihan

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

  • Walter Kowtoniuk

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

  • William Motley

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

Frequently asked questions

How many Pliant Therapeutics investors are on Angel Roster?

Angel Roster lists 22 Pliant Therapeutics investors. 9 of them (41%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (22), Private Equity Firms (15) and Finance Operator Investors (5). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Pliant Therapeutics investors invest in?

Among those that list a stage, the most common are Seed (8), Series B (4) and Series A (2).

Where are Pliant Therapeutics investors based?

Most are based in the United States (22).

Which companies have Pliant Therapeutics investors backed?

The most-backed portfolio companies among them are Blueprint Medicines (14), Jounce Therapeutics (14), Afferent Pharmaceuticals (14), Nurix Therapeutics (14) and CytomX Therapeutics (14).

How do I contact Pliant Therapeutics investors?

Create a free Angel Roster account to search and filter all 22, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.